[Dilip Davda] The company has posted a lacklustre performance so far. The sudden boost in bottom lines since FY21 onwards appears window dressing to pave the way for fancy pricing of this IPO. The sustainability of such performance going forward is a major concern. Based on its financial parameters, the issue is aggressively priced. It is operating on third party deals only and has no assets. Considering all these, there is no harm in ignoring this highly-priced IPO. Read detail review...

Evoq Remedies IPO Review by Members

Evoq Remedies IPO Reviews, analysis and views by popular members. Read Evoq Remedies Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Evoq Remedies IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Evoq Remedies IPO Review & Recommendations

Evoq Remedies IPO Review Summary from brokers and analysts

Evoq Remedies IPO Review by Dilip Davda (Avoid)

Evoq Remedies IPO Review by Members

Evoq Remedies IPO Review Summary by Members

Read more about Evoq Remedies IPO